Top Markets
#1 ADO Protocol ADO Protocol +329.02%
#2 GoPlus Security GoPlus Security +52.75%
#3 The Black Bull The Black Bull +38.37%
#4 Nockchain Nockchain +38.36%
#5 Starpower Starpower +34.57%
#6 Tutorial Tutorial +34.42%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +33.83%
#8 Fake World Assets Fake World Assets +26.29%
#9 GAIB AID GAIB AID +24.67%
#10 Verus Coin Verus Coin +20.41%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Rang in aandelen #33301
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Aandeelprijs
$0.4264
Laatst gesynchroniseerd: 2022-09-14
Marktkapitalisatie
$7.93M
Verandering (1 dag)
-16.44%
Verandering (1 jaar)
0.00%
Land
US
Handel Caladrius Biosciences, Inc. (CLBS)

Categorie

Healthcare
Aandelsplitsingen voor Caladrius Biosciences, Inc. (CLBS)
Het aandeel Caladrius Biosciences, Inc. (symbool: CLBS) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 17, 2026.
Eén aandeel CLBS dat vóór Aug 17, 2026 werd gekocht, staat nu gelijk aan 0 aandelen CLBS.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE